Cas:866145-38-2 2-(1,3-benzodioxol-5-yl)-3-bromoimidazo[1,2-a]pyrimidine manufacturer & supplier

We serve Chemical Name:2-(1,3-benzodioxol-5-yl)-3-bromoimidazo[1,2-a]pyrimidine CAS:866145-38-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(1,3-benzodioxol-5-yl)-3-bromoimidazo[1,2-a]pyrimidine

Chemical Name:2-(1,3-benzodioxol-5-yl)-3-bromoimidazo[1,2-a]pyrimidine
CAS.NO:866145-38-2
Synonyms:2-(1,3-benzodioxol-5-yl)-3-bromoimidazo[1,2-a]pyrimidine
Molecular Formula:C13H8BrN3O2
Molecular Weight:318.12600
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.83g/cm3
Index of Refraction:1.777
PSA:48.65000
Exact Mass:316.98000
LogP:2.88750

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-(1,3-benzodioxol-5-yl)-3-bromoimidazo[1,2-a]pyrimidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(1,3-benzodioxol-5-yl)-3-bromoimidazo[1,2-a]pyrimidine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(1,3-benzodioxol-5-yl)-3-bromoimidazo[1,2-a]pyrimidine Use and application,2-(1,3-benzodioxol-5-yl)-3-bromoimidazo[1,2-a]pyrimidine technical grade,usp/ep/jp grade.


Related News: Prime Minister Naftali Bennett, launching the campaign, said President Isaac Herzog would be the first to receive the booster, on Friday. Lysine, N2,N6-dicarboxy-, di-tert-butyl 1-ethyl ester manufacturers The QbD studies were designed concisely to minimize the use of the API and evaluate the critical product parameters that could affect the product quality attributes of the drug product, per FDA’s QbD guidance. 2-(3-fluoroanilino)-2-oxoacetic acid suppliers In 2021, the combo has raked in $818 million in the first half of the year alone for Novartis, a number that is already up 11% from last year. Comparatively, Roche reported $218 million in sales of Zelboraf in 2016, and revenue was not reported in its most recent mid-year update. 6-amino-2-methyl-5-nitro-1H-pyrimidin-4-one vendor & factory.